Lamictal and Cleft Palate Birth Defects

The FDA has issued a warning that Lamictal, a GlaxoSmithKline drug prescribed for bipolar disorder and epilepsy, has been linked to birth defects when taken by women in the first three months of pregnancy.

In a registry of 564 pregnant women who took the drug during the first trimester, five gave birth to babies with a cleft lip or cleft palate, which is a gap in the upper lip or roof of the mouth. The agency advises women taking Lamictal who are pregnant or thinking of becoming pregnant to speak with their doctor.

Glaxo Bipolar Drug May Be Tied to Defect

Related: bipolar disorder, epilepsy

Posted by Staff at 1:56 PM | Comments (1)